Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
8,600
Employees8,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
8,600
Employees8,600

ILMN Key Statistics

Market cap
25.42B
Market cap25.42B
Price-Earnings ratio
31.02
Price-Earnings ratio31.02
Dividend yield
Dividend yield
Average volume
1.96M
Average volume1.96M
High today
$177.22
High today$177.22
Low today
$166.80
Low today$166.80
Open price
$171.80
Open price$171.80
Volume
2.59M
Volume2.59M
52 Week high
$177.22
52 Week high$177.22
52 Week low
$81.76
52 Week low$81.76

Stock Snapshot

The current Illumina(ILMN) stock price is $168.06, with a market capitalization of 25.42B. The stock trades at a price-to-earnings (P/E) ratio of 31.02.

On 2026-06-04, Illumina(ILMN) stock moved within a range of $166.80 to $177.22. With shares now at $168.06, the stock is trading +0.8% above its intraday low and -5.2% below the session's peak.

Trading volume for Illumina(ILMN) stock has reached 2.59M, versus its average volume of 1.96M.

The stock's 52-week range extends from a low of $81.76 to a high of $177.22.

The stock's 52-week range extends from a low of $81.76 to a high of $177.22.

ILMN News

Simply Wall St 21h
Is Illumina Quietly Solidifying an End‑to‑End Oncology Moat With Deeper DRAGEN Integration?

In late May and early June 2026, Integrated DNA Technologies announced a collaboration with Illumina to link IDT’s xGen FFPE and cfDNA library prep to Illumina’...

Is Illumina Quietly Solidifying an End‑to‑End Oncology Moat With Deeper DRAGEN Integration?
TipRanks 3d
Top Illumina Executives Quietly Cash Out in Fresh Insider Stock Moves

New insider activity at Illumina ( (ILMN) ) has taken place on June 1, 2026. Illumina insiders have recently executed notable stock sales involving two senior...

TipRanks 3d
Integrated DNA Technologies enters collaboration with Illumina

Integrated DNA Technologies (DHR) announced a strategic collaboration with Illumina (ILMN) to enable a DRAGEN secondary analysis pipeline for IDT xGen FFPE and...

Analyst ratings

50%

of 22 ratings
Buy
50%
Hold
27.3%
Sell
22.7%

More ILMN News

TipRanks 3d
Illumina price target raised to $180 from $170 at Guggenheim

Guggenheim raised the firm’s price target on Illumina (ILMN) to $180 from $170 and keeps a Buy rating on the shares after having hosted the CFO and IR team for...

Simply Wall St 5d
Is It Too Late To Reassess Illumina After A 98% One Year Surge?

Wondering if Illumina at US$162.96 is priced for growth or still leaving some value on the table? This article walks through what the current share price might...

Is It Too Late To Reassess Illumina After A 98% One Year Surge?
Simply Wall St 7d
Assessing Illumina Valuation After Its New MRD Research Solution Expands Oncology Offering

Advertisement Why Illumina’s new MRD kit matters for the stock Illumina (ILMN) has drawn fresh attention after launching a whole genome based molecular residu...

Assessing Illumina Valuation After Its New MRD Research Solution Expands Oncology Offering

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.